Purdue slashes work force as generic OxyContin gets green light

With a generic version of OxyContin on the way, Purdue Pharma says it will be forced to lay off more than 800 workers, or 38 percent of its employees. OxyContin accounts for 75 percent of the company's revenues. Among those affected are 290 employees at the company's headquarters in Stamford, Connecticut. The company has other painkillers in the pipeline and is also developing a generic version of OxyContin.

- read this report from the San Diego Union-Tribune for more